The global cannabis market size is estimated to be valued at USD 20.5 billion in 2020. It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value. The growing medical applications of cannabis is driving the demand for cannabis.
Cannabis legalization is often viewed upon with dual perceptions wherein its legalization has been proven to be met with skepticism associated with possible abuse. Legalization of cannabis has allowed people to practice safe substance usage along with realizing its medicinal benefits. As a result of which, many countries are gradually legalizing the usage of cannabis across the globe. While most the countries across the globe have still not legalized the recreational use of cannabis, the approach to the usage and sales has been relaxed over the years. This has led to the growing popularity of usage of cannabis in various regions driving the growth of overall cannabis market.
Download PDF brochure:
As most countries in North America, Europe and South America are legalizing cannabis, there is a huge opportunity for the initialization and legalization of cannabis in the Asia Pacific region. China, being one of the major markets for industrial hemp, is expected to become one of major upcoming markets for industrial cannabis. Many key players operating in the cannabis industry, are waiting for the legislative development in the Asia Pacific region, expecting to generate huge opportunity for cannabis. Several countries in the region could be potential low-cost producers of cannabis with high production capacity.
By compound, the cannabis market is segmented into THC-dominant, CBD-dominant, and Balanced THC & CBD. CBD-dominant segment accounted for the second-largest market share in the overall cannabis market. It is considered one of the most therapeutic and healing part of the plant. Also, CBD-dominant strains are preferred by consumers suffering from chronic pain, inflammation, anxiety, and other chronic disorders.
By application, the market is segmented into medical and recreational. Recreational segment dominated the market owing to the high demand and consumption of cannabis for recreational purposes. Thus, the legalization of recreational applications has huge potential to translate into a large market.
Europe will be the fastest-growing region in the global cannabis market in the forecast period. The cannabis market in Europe is majorly driven by the increasing legalization of medical cannabis in the region coupled with healthcare system present in several Euroepan countries. Along with this, the demand for medical cannabis is rising in the region, further fueling the growth of European cannabis market.
Speak to Analyst:
This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), MedMen (US), Terra Tech Corp. (US), Aphria Inc. (Canada), VIVO Cannabis Inc. (Canada), The Cronos Group (Canada), Medical Marijuana Inc. (US), STENOCARE (Denmark), Tikun Olam (Israel), Organigram Holdings Inc. (Canada), Cresco Labs (US), Indiva (Canada), Curaleaf Holding Inc. (US), HEXO Corp. (Canada), Ecofibre Limited (Australia), Harvest Health & Recreation (US), Green Thumb Industries (US), Maricann Group Inc. (Canada), and TerrAscend (Canada).
Mar 11, 2022
Cannabis Market – Comprehensive Study Explore Huge Growth in Future
The global cannabis market size is estimated to be valued at USD 20.5 billion in 2020. It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value. The growing medical applications of cannabis is driving the demand for...
Read more »
Some individuals may not be listed above if they shared content without first signing in.